Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead

被引：29

作者：

Colao, Annamaria ^{[1
]}

de Nigris, Filomena ^{[2
]}

Modica, Roberta ^{[3
]}

Napoli, Claudio ^{[4
]}

机构：

[1] Federico II Univ Naples, Dept Clin Med & Surg, Unesco Chair Hlth Educ & Sustainable Dev, Naples, Italy

[2] Univ Campania Luigi Vanvitelli, Dept Precis Med, Naples, Italy

[3] Federico II Univ Naples, Dept Clin Med & Surg, Naples, Italy

[4] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci, Naples, Italy

来源：

FRONTIERS IN ENDOCRINOLOGY | 2020年 / 11卷

关键词：

epigenetics; neuroendocrine neoplasms; trials; biomarkers; neuroendocrine; neuroendocrine tumor; CIRCULATING TRANSCRIPT ANALYSIS; DNA METHYLATION; PANCREATIC ENDOCRINE; MICRORNA EXPRESSION; PROGNOSTIC RELEVANCE; GERMLINE MUTATION; CARCINOID-TUMORS; DOWN-REGULATION; THERAPY; CANCER;

D O I：

10.3389/fendo.2020.604341

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Neuroendocrine tumors, or NETs, are cancer originating in neuroendocrine cells. They are mostly found in the gastrointestinal tract or lungs. Functional NETs are characterized by signs and symptoms caused by the oversecretion of hormones and other substances, but most NETs are non-functioning and diagnosis in advanced stages is common. Thus, novel diagnostic and therapeutic strategies are warranted. Epigenetics may contribute to refining the diagnosis, as well as to identify targeted therapy interfering with epigenetic-sensitive pathways. The goal of this review was to discuss the recent advancement in the epigenetic characterization of NETs highlighting their role in clinical findings.

引用

页数：12

共 50 条

[31] Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract
Vicentini, Caterina
Fassan, Matteo
D'Angelo, Edoardo
Corbo, Vincenzo
Silvestris, Nicola
Nuovo, Gerard J.
Scarpa, Aldo
[J]. MOLECULES, 2014, 19 (02) : 2458 - 2468
[32] Neuroendocrine tumors in the ovary: histogenesis, pathologic differentiation, and clinical presentation
Vora, Moiz
Lacour, Robin A.
Black, Destin R.
Turbat-Herrera, Elba A.
Gu, Xin
[J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (03) : 659 - 665
[33] Epigenetic Regulation in Gastroenteropancreatic Neuroendocrine Tumors
Crabtree, Judy S.
[J]. FRONTIERS IN ONCOLOGY, 2022, 12
[34] Chromogranin A: any relevance in neuroendocrine tumors?
Kidd, Mark
Bodei, Lisa
Modlin, Irvin M.
[J]. CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2016, 23 (01) : 28 - 37
[35] Sirtuins and disease: the road ahead
Carafa, Vincenzo
Nebbioso, Angela
Altucci, Lucia
[J]. FRONTIERS IN PHARMACOLOGY, 2012, 3
[36] Radioembolization Dosimetry: The Road Ahead
Smits, Maarten L. J.
Elschot, Mattijs
Sze, Daniel Y.
Kao, Yung H.
Nijsen, Johannes F. W.
Iagaru, Andre H.
de Jong, Hugo W. A. M.
van den Bosch, Maurice A. A. J.
Lam, Marnix G. E. H.
[J]. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2015, 38 (02) : 261 - 269
[37] The epigenetics of brain tumors and its modulation during radiation: A review
Raviraj, Raghavi
Nagaraja, SunilGowda Sunnaghatta
Selvakumar, Ilakya
Mohan, Suma
Nagarajan, Devipriya
[J]. LIFE SCIENCES, 2020, 256
[38] Clinicopathological and epigenetic differences between primary neuroendocrine tumors and neuroendocrine metastases in the ovary
Mulders, Merijn C. F.
Verschuur, Anna Vera D.
de la Sabloniere, Quido G. de Lussanet
Roes, Eva Maria
Geisenberger, Christoph
Brosens, Lodewijk A. A.
de Herder, Wouter W.
van Velthuysen, Marie-Louise F.
Hofland, Johannes
[J]. JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2024, 10 (06)
[39] Epigenetics and testicular germ cell tumors
Buljubasic, Robert
Buljubasic, Maja
Bojanac, Ana Katusic
Ulamec, Monika
Vlahovic, Maja
Jezek, Davor
Bulic-Jakus, Floriana
Sincic, Nino
[J]. GENE, 2018, 661 : 22 - 33
[40] The road ahead: a brief guide to navigating the 2022 WHO classification of endocrine and neuroendocrine tumours
Juhlin, Carl Christofer
[J]. JOURNAL OF CLINICAL PATHOLOGY, 2025, 78 (01) : 1 - 10

← 1 2 3 4 5 →